Skip to content
Clinical Trials – home

Colitis Diagnostics

2 / 2 trials open to patients6 countries

In short

Colitis diagnostics involve a combination of physical examination, medical history review, laboratory tests, imaging studies, and endoscopic procedures to identify inflammation in the colon and determine its underlying cause. Early and accurate diagnosis is essential for starting appropriate treatment and preventing complications.

Key points

  • Persistent bloody diarrhea, abdominal pain, and urgent bowel movements are warning signs that require medical evaluation for possible colitis
  • Diagnosis begins with medical history and physical examination, followed by blood tests, stool tests, and imaging studies
  • Colonoscopy with tissue biopsy is essential for confirming the diagnosis and identifying the specific type of colitis
  • Different types of colitis have different causes, ranging from temporary infections to chronic autoimmune conditions
  • Clinical trials require standardized diagnostic tests including colonoscopy, blood work, and symptom scoring to ensure participants meet study criteria
  • People with ulcerative colitis for more than ten years need regular colonoscopy screening due to increased colon cancer risk
  • Emergency symptoms such as severe bleeding, extreme pain, or signs of perforation require immediate medical attention
  • Microscopic colitis can only be diagnosed through biopsy because the colon appears normal during visual examination

Introduction: Who Should Undergo Diagnostics

If you experience persistent symptoms such as bloody diarrhea, abdominal pain, frequent urgent bowel movements, or mucus in your stool, it is important to seek medical attention. These warning signs may indicate colitis, which is inflammation of the colon that can range from temporary to chronic and severe.

You should especially consider getting tested if symptoms last more than a few days or if you notice worsening patterns. People with a family history of inflammatory bowel disease, those who have recently taken antibiotics, or individuals who have consumed contaminated food or water should also be alert to symptoms and seek early evaluation.

Children and infants showing signs such as persistent diarrhea, blood in stool, fever, or failure to thrive require prompt medical evaluation. In babies, allergic colitis may present after exposure to cow's milk protein through breastfeeding or formula.

Older adults experiencing sudden onset of severe abdominal pain and bloody diarrhea may have ischemic colitis, a condition where the colon does not receive enough blood. This is a medical concern that needs immediate attention, as it can lead to serious complications.

Classic Diagnostic Methods

Diagnosing colitis begins with your healthcare provider taking a detailed medical history. They will ask about your symptoms, when they started, what you were eating and drinking before symptoms appeared, any medications you are currently taking, and whether you have any existing health conditions. This conversation helps narrow down possible causes and guides the selection of appropriate tests.

After reviewing your history, your doctor will perform a physical examination. During this exam, they will check for signs of abdominal tenderness, bloating, or masses. They may also perform a digital rectal exam, which involves gently inserting a gloved finger into the rectum to check for abnormalities, tenderness, or blood.

Blood Tests

Blood tests are commonly ordered to look for signs of inflammation, infection, or complications. These tests can reveal whether you have anemia, which is a condition where you do not have enough red blood cells to carry oxygen throughout your body. Anemia can occur when ulcers in your colon bleed over time.

Blood tests may also check for markers of inflammation in your body, such as elevated white blood cell counts or specific proteins that increase during inflammation. These markers help doctors understand how active the disease is and whether your body is fighting an infection.

Stool Tests

Stool tests involve collecting a sample of your bowel movement and sending it to a laboratory for analysis. These tests can identify the presence of white blood cells, blood, mucus, or certain proteins that suggest inflammation in your colon. Stool samples can also help rule out infections caused by bacteria, viruses, or parasites.

If your doctor suspects pseudomembranous colitis, they will test your stool for a toxin produced by the bacterium called C. diff (clostridioides difficile). This type of colitis often happens after taking antibiotics that upset the normal balance of bacteria in your intestines.

Imaging Studies

Imaging tests allow doctors to see inside your body without surgery. A standard X-ray of your abdomen can quickly check for severe complications such as a widened colon, which is a sign of toxic megacolon, or a hole in the colon wall, known as perforation. Both of these conditions are medical emergencies.

A CT scan (computed tomography scan) creates detailed cross-sectional images of your abdomen and colon. This test helps doctors see the extent and location of inflammation and can reveal complications such as abscesses or blockages. CT scans are particularly useful when symptoms are severe or when other tests do not provide enough information.

An MRI scan (magnetic resonance imaging) uses magnets and radio waves instead of radiation to create detailed images of your intestines. MRI is sometimes preferred for younger patients or those who need repeated imaging, as it does not expose you to radiation.

Endoscopic Procedures

Endoscopic tests allow doctors to look directly inside your colon using a thin, flexible tube with a light and camera attached to the end. These procedures are essential for diagnosing the type of colitis you have and assessing the severity of inflammation.

Colonoscopy is the most comprehensive endoscopic test. During this procedure, the doctor inserts the scope through your anus and guides it through your entire colon. This allows them to examine the inner lining of the colon and look for signs of inflammation, ulcers, or other abnormalities. During the colonoscopy, your doctor can also take small tissue samples called biopsies. These samples are sent to a laboratory where they are examined under a microscope to confirm the diagnosis and rule out other conditions such as cancer.

Flexible sigmoidoscopy is a similar procedure, but the scope only goes into the lower part of your colon, called the sigmoid colon, and the rectum. This test is quicker and may be done instead of a full colonoscopy if your colon is severely inflamed and a full examination could be risky.

Tissue biopsies collected during these procedures are necessary to make a definitive diagnosis. The microscopic examination helps distinguish between different types of colitis, such as ulcerative colitis, Crohn's disease, microscopic colitis, or infectious colitis.

Additional Specialized Tests

In certain cases, additional tests may be needed to pinpoint the cause or assess complications. Barium enema is an older imaging test where a liquid containing barium is inserted into your rectum before X-rays are taken. The barium coats the inside of your colon, making it easier to see abnormalities on the X-ray images.

If your doctor suspects ischemic colitis, they may order tests to check the blood flow to your intestines. These can include special imaging studies that look at the blood vessels supplying your colon to identify blockages or narrowing.

For babies suspected of having allergic colitis, doctors may recommend eliminating certain proteins from the mother's diet if breastfeeding, or switching to a hypoallergenic formula. Improvement of symptoms after dietary changes can help confirm the diagnosis.

Diagnostics for Clinical Trial Qualification

When patients are being considered for enrollment in clinical trials testing new treatments for colitis, they must undergo thorough and standardized diagnostic evaluations. These tests ensure that participants truly have the condition being studied and that they meet specific criteria regarding disease severity and activity.

Clinical trials often require confirmation of the diagnosis through colonoscopy with biopsies. The tissue samples must show clear evidence of inflammation consistent with the type of colitis being studied, such as ulcerative colitis or Crohn's disease affecting the colon. The biopsy results help researchers classify patients accurately and ensure that the trial includes only those who will benefit from the experimental treatment.

Blood tests are used to measure inflammation markers and assess overall health. Common markers include C-reactive protein and erythrocyte sedimentation rate, which indicate how much inflammation is present in your body. These baseline measurements allow researchers to track whether the treatment reduces inflammation over time.

Stool tests may be required to rule out active infections, particularly C. diff or other bacterial causes of colitis. Clinical trials typically exclude patients with infectious colitis because the treatment being tested is designed for inflammatory or autoimmune forms of the disease, not infections.

Imaging studies such as CT scans or MRI scans may be used to document the extent and location of disease before treatment begins. These images provide a visual record that can be compared to images taken later in the trial to measure improvement or progression.

Many clinical trials use standardized scoring systems to rate disease severity. For example, in ulcerative colitis trials, doctors may use endoscopic scores that rate the appearance of the colon lining during colonoscopy, including the presence of ulcers, bleeding, and the extent of inflammation. These scores help determine whether a patient's disease is mild, moderate, or severe, which influences whether they qualify for the trial.

Patients may also need to complete questionnaires about their symptoms, quality of life, and how the disease affects their daily activities. These questionnaires provide important information about how the disease impacts patients beyond what medical tests can measure.

Some trials require patients to have failed previous standard treatments before they can enroll. This means you may need to provide documentation showing that you tried medications such as aminosalicylates, corticosteroids, or immunosuppressants without adequate symptom control. This ensures that the trial focuses on patients who need new treatment options.

Throughout the clinical trial, repeated diagnostic tests are performed at regular intervals to monitor your response to treatment. These follow-up tests often include blood work, stool tests, and repeat colonoscopies with biopsies. The data collected from these tests help researchers determine whether the experimental treatment is effective and safe.

Prognosis and Survival Rate

Prognosis

The outlook for people with colitis varies greatly depending on the type and severity of the condition. Temporary forms of colitis, such as infectious colitis caused by food poisoning, usually resolve completely within days to weeks with appropriate treatment and supportive care. Once the infection clears, most people recover fully without long-term effects.

In contrast, chronic forms of colitis such as ulcerative colitis and Crohn's disease are lifelong conditions that cannot be cured. However, with proper medical management, most people can achieve periods of remission where they have few or no symptoms. During remission, which can last for weeks, months, or even years, patients can lead active and normal lives.

The disease course of inflammatory bowel disease is unpredictable and varies from person to person. Some people experience only one or two flare-ups in their lifetime, while others have chronic continuous symptoms or frequent relapses. Factors that may affect prognosis include the extent of colon involvement, how early treatment begins, adherence to medications, and lifestyle factors such as stress management and diet.

Complications from severe, long-term colitis can significantly impact prognosis. Chronic inflammation can weaken the colon walls, increasing the risk of perforation, which is a medical emergency. Toxic megacolon, where the colon becomes severely widened and stops functioning, is another serious complication that requires urgent treatment. People with ulcerative colitis for more than ten years also face an increased risk of developing colon cancer, which makes regular screening essential.

Quality of life can be significantly affected by colitis, particularly during flare-ups. Frequent urgent bowel movements, pain, fatigue, and the unpredictability of symptoms can interfere with work, social activities, and personal relationships. However, advances in treatment options, including new medications and surgical techniques, have improved outcomes and quality of life for many patients.

With early diagnosis, appropriate treatment, regular monitoring, and healthy lifestyle practices, many people with chronic colitis can control their symptoms and minimize the impact on their daily lives. Close collaboration between patients and their healthcare team is essential for achieving the best possible outcomes.

Survival rate

For most types of colitis, survival rates are generally favorable, especially when the condition is diagnosed early and managed appropriately. Temporary forms of colitis caused by infections rarely result in death when treated promptly, and most patients recover completely.

People with chronic inflammatory bowel diseases such as ulcerative colitis typically have a normal or near-normal life expectancy when their disease is well-controlled with medication and regular monitoring. However, severe complications such as toxic megacolon, perforation, or severe bleeding can become life-threatening if not treated urgently.

The increased risk of colon cancer in people with long-standing ulcerative colitis is an important consideration. Regular colonoscopy screening helps detect precancerous changes or early-stage cancer when treatment is most effective, which improves survival outcomes for those who develop cancer.

Overall, the prognosis for people with colitis has improved significantly over recent decades due to better understanding of the disease, more effective medications, and advances in surgical techniques. Most people with colitis can expect to live full and productive lives with appropriate medical care.

Did you know?

  1. Ulcerative colitis always starts in the rectum and spreads upward toward the colon, leaving no healthy tissue in its path, which helps doctors distinguish it from other types of inflammatory bowel disease during colonoscopy.[3]
  2. Microscopic colitis, a common cause of chronic watery diarrhea especially in the elderly, can only be diagnosed through biopsy because the colon looks completely normal during colonoscopy examination.[4]
  3. Approximately 70% of healthcare decisions depend on diagnostic test results, yet only 3 to 5% of healthcare budgets are allocated to diagnostic services worldwide.[23]

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Colitis

Recruiting trials first

See all 2 trials →
Quick filters

2 clinical trials in this condition

Colitis ulcerative+2

Recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Mirikizumab
  • Sponsor:Eli Lilly & Co.

Colitis

Recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Infliximab
  • Sponsor:Odense University Hospital
See all 2 trials →filters applied: condition = Colitis

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).